BRPI0507352A - reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila - Google Patents

reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila

Info

Publication number
BRPI0507352A
BRPI0507352A BRPI0507352-9A BRPI0507352A BRPI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A
Authority
BR
Brazil
Prior art keywords
tetrazol
preparation
coupling reactions
biphenyl derivatives
reactions useful
Prior art date
Application number
BRPI0507352-9A
Other languages
English (en)
Inventor
Christoph Krell
Hans Hirt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0507352A publication Critical patent/BRPI0507352A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

'REAçõES DE COPLAMENTO úTEIS NA PREPARAçãO DE DERIVADOS DE (1H-TETRAZOL-5-IL)-BIFENILA". A presente invenção refere-se a um processo para a fabricação de intermediários que podem ser usados para a fabricação de ARbs (também denominados antagonistas de receptor de angiotensina II ou antagonistas de receptor de AT1), compreendendo como uma característica estrutural comum, um anel (1H-tetrazol-5-il)- bifenila.
BRPI0507352-9A 2004-02-02 2005-02-01 reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila BRPI0507352A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402262.0A GB0402262D0 (en) 2004-02-02 2004-02-02 Process for the manufacture of organic compounds
PCT/EP2005/000978 WO2005075462A1 (en) 2004-02-02 2005-02-01 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives

Publications (1)

Publication Number Publication Date
BRPI0507352A true BRPI0507352A (pt) 2007-07-03

Family

ID=31985494

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507352-9A BRPI0507352A (pt) 2004-02-02 2005-02-01 reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila

Country Status (19)

Country Link
US (2) US7700784B2 (pt)
EP (2) EP1716140A1 (pt)
JP (1) JP2007519684A (pt)
KR (1) KR20060128993A (pt)
CN (1) CN100528868C (pt)
AU (1) AU2005211500B2 (pt)
BR (1) BRPI0507352A (pt)
CA (1) CA2553246A1 (pt)
CO (1) CO5700717A2 (pt)
EC (1) ECSP066727A (pt)
GB (1) GB0402262D0 (pt)
IL (2) IL176904A0 (pt)
MA (1) MA28427B1 (pt)
NO (1) NO20063920L (pt)
NZ (1) NZ548690A (pt)
RU (2) RU2426728C2 (pt)
TN (1) TNSN06238A1 (pt)
WO (1) WO2005075462A1 (pt)
ZA (1) ZA200605462B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
JP5023720B2 (ja) * 2006-08-04 2012-09-12 東ソー株式会社 ハロゲン化ビフェニル類の製造方法
PL2295035T3 (pl) * 2007-11-06 2016-11-30 Podwójne działanie kompozycji farmaceutycznych opartych na superstrukturach antagonisty/blokera receptora angiotensyny (arb) oraz inhibitora obojętnej endopeptydazy (nep)
PE20091364A1 (es) 2008-01-17 2009-10-13 Novartis Ag Proceso para la preparacion de inhibidores de nep
JP5203144B2 (ja) * 2008-11-07 2013-06-05 東ソー株式会社 スチレン類の製造方法
JP5261140B2 (ja) * 2008-11-07 2013-08-14 東ソー株式会社 ビニル芳香族化合物の製造方法
EP2609075B1 (en) 2010-08-23 2016-03-16 Novartis AG Process for the preparation of intermediates for the manufacture of nep inhibitors
SG187843A1 (en) * 2010-08-27 2013-03-28 Teijin Pharma Ltd Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
CN103467341B (zh) * 2013-08-29 2015-02-25 河南师范大学 一种沙坦联苯的制备方法
CN104987327A (zh) * 2015-07-13 2015-10-21 朱绍清 一种四唑类衍生物的催化合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69033469T2 (de) 1989-06-14 2000-09-07 Smithkline Beecham Corp., Philadelphia Imidazoalkensäure
ATE134624T1 (de) 1990-02-19 1996-03-15 Ciba Geigy Ag Acylverbindungen
GB9005354D0 (en) * 1990-03-09 1990-05-02 Glaxo Group Ltd Chemical compounds
TW201738B (pt) 1990-03-20 1993-03-11 Sanofi Co
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
TW226375B (pt) 1991-10-24 1994-07-11 American Home Prod
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
EP0550313A1 (fr) 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
PT788487E (pt) 1994-10-27 2001-11-30 Novartis Ag Processo para a preparacao de tetrazoles
JP3763869B2 (ja) * 1994-12-26 2006-04-05 東ソー・ファインケム株式会社 ビフェニル化合物の製造方法
US5922898A (en) * 1997-04-08 1999-07-13 Catalytica Pharmaceuticals, Inc. Process for preparing biaryl compounds
DE10057679A1 (de) 2000-11-21 2002-05-29 Forschungszentrum Juelich Gmbh Brennstoffzellenstapel mit Kreislaufführung
HRP20050082A2 (en) * 2002-07-19 2005-06-30 Memory Pharmaceuticals Corporation 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
DE602004015071D1 (de) * 2003-02-05 2008-08-28 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
AU2004256042A1 (en) 2003-06-05 2005-01-20 Genentech, Inc. BlyS antagonists and uses thereof

Also Published As

Publication number Publication date
RU2010136996A (ru) 2012-03-20
IL176904A0 (en) 2006-12-10
ECSP066727A (es) 2006-10-31
RU2426728C2 (ru) 2011-08-20
KR20060128993A (ko) 2006-12-14
EP2246348A1 (en) 2010-11-03
MA28427B1 (fr) 2007-02-01
CN1914197A (zh) 2007-02-14
WO2005075462A1 (en) 2005-08-18
GB0402262D0 (en) 2004-03-10
CA2553246A1 (en) 2005-08-18
ZA200605462B (en) 2009-06-24
EP1716140A1 (en) 2006-11-02
NO20063920L (no) 2006-10-30
TNSN06238A1 (en) 2007-12-03
CN100528868C (zh) 2009-08-19
RU2006131460A (ru) 2008-03-10
AU2005211500A1 (en) 2005-08-18
US20070129413A1 (en) 2007-06-07
JP2007519684A (ja) 2007-07-19
IL208409A0 (en) 2011-08-01
US20100152458A1 (en) 2010-06-17
AU2005211500B2 (en) 2009-04-02
US7700784B2 (en) 2010-04-20
CO5700717A2 (es) 2006-11-30
NZ548690A (en) 2009-08-28

Similar Documents

Publication Publication Date Title
WO2009140624A3 (en) Glucokinase activators
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
MA33198B1 (fr) Anticorps anti-her di-spécifiques
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
BRPI0712819B8 (pt) composto para liberação controlada de opióides fenólicos, processo para a preparação do referido composto e composição farmacêutica
TW200637614A (en) Bendamustine pharmaceutical compositions
BRPI0508622A (pt) compostos de bifenil úteis como antagonistas do receptor muscarìnico
TW200745149A (en) Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
BRPI0910182A2 (pt) composto de fórmula (i), composição farmacêutica, método de tratamento de um distúrbio e uso de um composto"
WO2010109334A3 (en) Thienopyrimidinedione derivatives as trpa1 modulators
CR20110314A (es) Compuestos orgánicos
MA30725B1 (fr) Administration d'inhibiteurs de la dipeptidyl peptidase
MX2009004780A (es) Derivados de quiniclidina de acido (hetero) arilcicloheptano carboxilico como antagonistas del receptor muscarinico.
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
UY28538A1 (es) Derivados de fenil-piperazina como moduladores de receptores muscarínicos
PA8632201A1 (es) Derivados de fenol y tiofenol 3-0 4-monosustituidos utiles como ligandos de h3
BRPI0507352A (pt) reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila
BRPI0918517B8 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
BRPI0411738A (pt) compostos orgánicos
BRPI0407913A (pt) antagonistas receptores de ccr-3
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE, CONFORME ART. 10 DA RES. 124/06.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.